Reviva Pharmaceuticals Holdings, Inc. SC 13D and SC 13D/A reports

Location
10080 N Wolfe Road, Suite Sw3 200, Cupertino, California
State of incorporation
Delaware
Fiscal year end
December 31
Data updated at
6/1/2024, 01:28 AM
Form type Sec Links Description Filing date Reporting date
SC 13D/A Report May 31, 2024
SC 13D/A Report SCHEDULE 13D/A Feb 16, 2024
SC 13D/A Report Nov 30, 2023
SC 13D/A Report SCHEDULE 13D/A May 5, 2023
SC 13D/A Report SC 13D/A Sep 12, 2022
SC 13D/A Report SCHEDULE 13D/A Jun 14, 2021
SC 13D/A Report SC 13D/A Jun 3, 2021
SC 13D/A Report SCHEDULE SC 13D/A Jan 19, 2021
SC 13D/A Report SC 13D/A Jan 19, 2021
SC 13D/A Report SCHEDULE 13D/A Jan 19, 2021
SC 13D Report SCHEDULE 13D Dec 21, 2020
SC 13D Report SC 13D Sep 4, 2018